Pancreatic Cancer Research

ResearcherNational Hospital OrganizationActive in the last 2 years

Atsushi Yamaguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6916-4108; OpenAlex author ID A5042681436. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Clinical outcomes and recurrence patterns in pancreatic ductal adenocarcinoma diagnosed at an early stage: insights from a multicenter cohort study in Japan. Co-author DOI 10.1007/s00535-025-02340-x↗
  2. Genetically proxied risk and protective factors for pancreatic cancer: a systematic review and meta-analysis of Mendelian randomization studies. Co-author DOI 10.21037/jgo-2025-305↗
  3. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemothera… Co-author DOI 10.1007/s00595-024-02824-y↗
  4. Effect of body fat mass loss on prognosis of radical resection for pancreatic ductal adenocarcinoma based on bioelectrical impedance analysis. Co-author DOI 10.1186/s12893-024-02315-4↗
  5. Metastatic pancreatic ductal adenocarcinoma followed by a fatal diffuse large B-cell lymphoma: A rare case report and literature review. Co-author DOI 10.1097/md.0000000000033217↗
  6. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study. First author DOI 10.1186/s12876-023-02779-3↗
  7. Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: … Co-author DOI 10.3390/diagnostics13162696↗
  8. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.14670/hh-18-397↗
  9. Effectiveness of Abdominal Ultrasonography for Improving the Prognosis of Pancreatic Cancer during Medical Checkup: A Single Center Retrospective Analysis. Co-author DOI 10.3390/diagnostics12122913↗
  10. Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study. Co-author DOI 10.3390/diagnostics11020287↗
  11. FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan. Co-author DOI 10.1016/j.pan.2020.07.006↗
  12. [Two cases of pancreatic cancer treated with FOLFIRINOX regimen and G-CSF prophylaxis at the standard therapeutic dose]. Last author PMID 25981661↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takeshi Sudo · 5 shared papers, 2022–2024 · strength 0.83
  2. Shin’ya Takahashi · 3 shared papers, 2024–2026 · strength 0.64
  3. Sho Tazuma · 3 shared papers, 2023–2024 · strength 0.55
  4. Hirotaka Tashiro · 3 shared papers, 2022–2024 · strength 0.54
  5. Masanobu Yukutake · 3 shared papers, 2021–2026 · strength 0.49
  6. Yasutaka Ishii · 3 shared papers, 2021–2026 · strength 0.49
  7. Juri Ikemoto · 3 shared papers, 2021–2026 · strength 0.49
  8. Keiji Hanada · 3 shared papers, 2021–2026 · strength 0.49
  9. Tomoyuki Minami · 3 shared papers, 2021–2026 · strength 0.49
  10. Kenichiro Uemura · 2 shared papers, 2024–2026 · strength 0.45
  11. Hiroshi Kohno · 3 shared papers, 2022–2023 · strength 0.44
  12. Naohiro Kato · 3 shared papers, 2022–2023 · strength 0.44
  13. Yoshiyuki Shibata · 2 shared papers, 2024 · strength 0.40
  14. Shinya Nakamura · 2 shared papers, 2023–2026 · strength 0.39
  15. Akira Ishikawa · 2 shared papers, 2022–2024 · strength 0.35
  16. Richard J. Bold · 1 shared paper, 2025 · strength 0.27
  17. Li Zhang · 1 shared paper, 2025 · strength 0.27
  18. Fada Luo · 1 shared paper, 2025 · strength 0.27
  19. Somashekar Gopala Krishna · 1 shared paper, 2025 · strength 0.27
  20. Shiro Oka · 1 shared paper, 2026 · strength 0.24
  21. Wataru Yasuif · 1 shared paper, 2022 · strength 0.15
  22. Naoto Hadano · 1 shared paper, 2022 · strength 0.15
  23. Shiro Oka · 1 shared paper, 2023 · strength 0.14
  24. Tomofumi Tsuboi · 1 shared paper, 2021 · strength 0.10
  25. Akinori Shimizu · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.